Niedermayr Katharina, Pölzl Gerhard, Scholl-Bürgi Sabine, Fauth Christine, Schweigmann Ulrich, Haberlandt Edda, Albrecht Ursula, Zlamy Manuela, Sperl Wolfgang, Mayr Johannes A, Karall Daniela
Department of Child and Adolescent Health, Pediatrics I/III, Medical University of Innsbruck, Innsbruck, Austria.
University Hospital for Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
Congenit Heart Dis. 2018 Sep;13(5):671-677. doi: 10.1111/chd.12634. Epub 2018 Aug 21.
In general, a mitochondrial disorder is diagnosed on the basis of symptom combinations and confirmed by genetic findings. However, patients carrying the m.3243A>G mutation in the mitochondrial tRNA leucine 1 (MT-TL1) do not always meet all the proposed criteria for the most frequently encountered mitochondrial syndrome "MELAS," an acronym for Mitochondrial Encephalomyopathy, Lactic Acidosis, and at least one Stroke-like episode. We here present various phenotypic characteristics of the mitochondrial mutation m.3243A>G with particular focus on cardiac manifestations.
We followed nine patients (1 month to 68 years old; median 42 years; four female and five male) from nine different families with this m.3243A>G mutation in the MT-TL1. The classical "MELAS" criteria are met by only three of these patients. Electrocardiography (ECG) shows preexcitation pattern with short PR intervals and delta waves (Wolff-Parkinson-White) in three patients and sick sinus syndrome plus atrioventricular block I in one patient. Hypertrophic cardiomyopathy was found in eight patients with moderate to severe regurgitation of various valves.
Cardiac manifestation can encompass hypertrophic or dilated cardiomyopathy, as well as preexcitation syndromes or conduction delay. In general, the clinical presentation to meet the "MELAS" criteria varies due to heteroplasmy. Thus, cardiologists should screen patients with unexplained cardiac features in the context of deafness, short stature and learning disabilities for mtDNA mutations, especially the m.3243A>G mutation. A clear diagnosis is essential as a basis for prognostic advice concerning the disease course and clinical impact on family testing.
一般来说,线粒体疾病是根据症状组合进行诊断,并通过基因检测结果加以证实。然而,携带线粒体亮氨酸转运RNA 1(MT-TL1)基因m.3243A>G突变的患者并不总是符合最常见的线粒体综合征“MELAS”(线粒体脑肌病、乳酸酸中毒和卒中样发作的英文缩写)所提出的所有标准。我们在此呈现线粒体m.3243A>G突变的各种表型特征,特别关注心脏表现。
我们追踪了来自9个不同家庭的9例携带MT-TL1基因m.3243A>G突变的患者(年龄从1个月至68岁;中位年龄42岁;4名女性,5名男性)。这些患者中只有3例符合经典的“MELAS”标准。心电图(ECG)显示3例患者有短PR间期和δ波(预激综合征),1例患者有病态窦房结综合征加一度房室传导阻滞。8例患者发现肥厚型心肌病,伴有各种瓣膜中度至重度反流。
心脏表现可包括肥厚型或扩张型心肌病,以及预激综合征或传导延迟。一般来说,由于异质性,临床表现符合“MELAS”标准的情况各不相同。因此,心脏病专家应在耳聋、身材矮小和学习障碍的背景下,对具有不明原因心脏特征的患者进行线粒体DNA突变筛查,尤其是m.3243A>G突变。明确诊断对于提供有关疾病进程的预后建议以及对家族检测的临床影响至关重要。